As per this study the Global Avian Flu Treatment Market was valued USD XX MN (by revenue) in 2019 and is anticipated to reach USD XX MN by 2026 with a CAGR of XX%.
Avian flu, which is generally known as bird flu, is an infectious viral disease commonly found in waterfowl birds such as ducks and geese. Avian flu is an uncommon disease in humans but can get infected by close contact with infected species. Avian flu can cause infection in poultry and livestock. Common viruses which can infect humans are A (H5N1) and A (H7N9). People working in poultry where infected species are present may possess a high risk of avian flu disease, or consuming raw eggs and uncooked meats.
The increase in outbreaks of avian flu in the poultry industry and awareness about diagnosis among infected patients are driving avian flu treatment market growth. However, resistance to existing antivirals can negatively impact the sales of antiviral drugs since it will lead to a change in treatment guidelines, which is likely to restrain market growth. Whereas rising investment on healthcare sector along with the better diagnosis arising owing to clinical representation is expected to enhance the market presence over the forecast period.
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of avian flu treatment.
The broad avian flu treatment market has been sub-grouped into type and end-user. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
- Antiviral Agents
- Institutional Health Centers
- Online Pharmacies
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for avian flu treatment in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
Global Avian Flu Treatment Market Share by Region (Representative Graph)
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the avian flu treatment market include Abbott, BioCryst Pharmaceuticals, Cipla, Forrest Pharmaceuticals, Gilead Sciences, GlaxoSmithKline, Macleods Pharmaceuticals, Pfizer, Roche, Sanofi, and Sinovac Biotech. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.